chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Bronchitis bacterial, COVID-19, Chest X-ray abnormal
Clinical narrative: Narrative: COVID infection following COVID vaccine series 04/12, Pfizer, dose #1 05/14, Pfizer, dose #2 12/23 COVID swab, result: detected 12/21 pt cc: cough, diarrhea, fatigue, headache, loss of taste or smell, dyspnea exposure: unknown 12/23 ESR: 35 12/23 SARS-COV-2 Variant Sequencing: pending 12/23 pt admit to ED cc: "1 week hx productive cough with brownish phlegm, fever, chills and ST" dx: Acute Viral Syndrome, URI. and COVID with secondary bacterial Bronchitis LOS: 1 day 12/23 CXR impression: No focal consolidation.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Dyspnoea, Fatigue, Headache
Clinical narrative: Narrative: COVID infection following COVID vaccine series 04/12, Pfizer, dose #1 05/14, Pfizer, dose #2 12/23 COVID swab, result: detected 12/21 pt cc: cough, diarrhea, fatigue, headache, loss of taste or smell, dyspnea exposure: unknown 12/23 ESR: 35 12/23 SARS-COV-2 Variant Sequencing: pending 12/23 pt admit to ED cc: "1 week hx productive cough with brownish phlegm, fever, chills and ST" dx: Acute Viral Syndrome, URI. and COVID with secondary bacterial Bronchitis LOS: 1 day 12/23 CXR impression: No focal consolidation.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Productive cough, Pyrexia, SARS-CoV-2 test positive, Sputum discoloured
Clinical narrative: Narrative: COVID infection following COVID vaccine series 04/12, Pfizer, dose #1 05/14, Pfizer, dose #2 12/23 COVID swab, result: detected 12/21 pt cc: cough, diarrhea, fatigue, headache, loss of taste or smell, dyspnea exposure: unknown 12/23 ESR: 35 12/23 SARS-COV-2 Variant Sequencing: pending 12/23 pt admit to ED cc: "1 week hx productive cough with brownish phlegm, fever, chills and ST" dx: Acute Viral Syndrome, URI. and COVID with secondary bacterial Bronchitis LOS: 1 day 12/23 CXR impression: No focal consolidation.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Upper respiratory tract infection, Viral infection
Clinical narrative: Narrative: COVID infection following COVID vaccine series 04/12, Pfizer, dose #1 05/14, Pfizer, dose #2 12/23 COVID swab, result: detected 12/21 pt cc: cough, diarrhea, fatigue, headache, loss of taste or smell, dyspnea exposure: unknown 12/23 ESR: 35 12/23 SARS-COV-2 Variant Sequencing: pending 12/23 pt admit to ED cc: "1 week hx productive cough with brownish phlegm, fever, chills and ST" dx: Acute Viral Syndrome, URI. and COVID with secondary bacterial Bronchitis LOS: 1 day 12/23 CXR impression: No focal consolidation.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Alanine aminotransferase, Aspartate aminotransferase, COVID-19, Cough, Dyspnoea
Clinical narrative: Narrative:  Patient is 75 y/o male who presented to the ER on 12/7/21 with cough, fever, body aches, and shortness of breath for the 5 days. Emesis after coughing. Diagnosed with COVID-19 3 days ago at an outside facility and presented to the ER on 12/5/21 feeling worse. Oxygen saturations at home and ER were less than 90% on room air. Transaminitis/acute hepatitis suspected to be secondary to COVID infection. Admitted and treated with dexamethasone (12/7-12/17) and remdesivir (12/7-12/12). Discharged 12/25/21. Vaccinated with Janssen one dose vaccine on 3/30/21 at a facility. Second "booster dose" on 11/30/21 through the health care facility. PMH: OSA, CAD, and emphysema.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal, Hepatitis acute, Hypertransaminasaemia, Pain, Pyrexia
Clinical narrative: Narrative:  Patient is 75 y/o male who presented to the ER on 12/7/21 with cough, fever, body aches, and shortness of breath for the 5 days. Emesis after coughing. Diagnosed with COVID-19 3 days ago at an outside facility and presented to the ER on 12/5/21 feeling worse. Oxygen saturations at home and ER were less than 90% on room air. Transaminitis/acute hepatitis suspected to be secondary to COVID infection. Admitted and treated with dexamethasone (12/7-12/17) and remdesivir (12/7-12/12). Discharged 12/25/21. Vaccinated with Janssen one dose vaccine on 3/30/21 at a facility. Second "booster dose" on 11/30/21 through the health care facility. PMH: OSA, CAD, and emphysema.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Vomiting
Clinical narrative: Narrative:  Patient is 75 y/o male who presented to the ER on 12/7/21 with cough, fever, body aches, and shortness of breath for the 5 days. Emesis after coughing. Diagnosed with COVID-19 3 days ago at an outside facility and presented to the ER on 12/5/21 feeling worse. Oxygen saturations at home and ER were less than 90% on room air. Transaminitis/acute hepatitis suspected to be secondary to COVID infection. Admitted and treated with dexamethasone (12/7-12/17) and remdesivir (12/7-12/12). Discharged 12/25/21. Vaccinated with Janssen one dose vaccine on 3/30/21 at a facility. Second "booster dose" on 11/30/21 through the health care facility. PMH: OSA, CAD, and emphysema.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Inappropriate schedule of product administration, Malaise, Respiratory symptom, SARS-CoV-2 test positive
Clinical narrative: Narrative:  Patient received immunization for COVID 19 but tested positive on 1/3/22 with accompanying respiratory symptoms. Was evaluated in ER and discharged home. At time of ER visit patient reported he had experienced symptoms for approximately 1.5 weeks.
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19 pneumonia, Chemotherapy, Computerised tomogram abdomen abnormal, Diverticulitis, Fatigue
Clinical narrative: Narrative: Patient is on 80 y/o male who presented to ER on 12/6/21 with fatigue, right flank pain, and intermittent bloody stools after chemo for multiple myeloma for 1-2 weeks. PMH includes HTN, CHF, COPD, obesity, aortic stenosis, cardiomyopathy, and cardiac defibrillator. CT was consistent with diverticulitis probably early as well as confirmation of COVID-19 pneumonia. Admitted for further eval and treatment, also in the setting of immunosuppression. Treated with dexamethasone (12/6-12/14) and remdesivir (12/6-12/10). Discharged on 12/14 with supportive medications including albuterol, benzonatate, guaifenesin, and throat lozenges. To continue home oxygen.
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Flank pain, Haematochezia, Immunosuppression, Plasma cell myeloma, SARS-CoV-2 test positive
Clinical narrative: Narrative: Patient is on 80 y/o male who presented to ER on 12/6/21 with fatigue, right flank pain, and intermittent bloody stools after chemo for multiple myeloma for 1-2 weeks. PMH includes HTN, CHF, COPD, obesity, aortic stenosis, cardiomyopathy, and cardiac defibrillator. CT was consistent with diverticulitis probably early as well as confirmation of COVID-19 pneumonia. Admitted for further eval and treatment, also in the setting of immunosuppression. Treated with dexamethasone (12/6-12/14) and remdesivir (12/6-12/10). Discharged on 12/14 with supportive medications including albuterol, benzonatate, guaifenesin, and throat lozenges. To continue home oxygen.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Blood lactic acid normal, Chest X-ray normal, Hypoxia, Inflammation, Laboratory test normal
Clinical narrative: Narrative: 78 yo MALE with history of psychotic depression, GERD, PTSD,  cognitive and PUD. 78 yo MALE with history of psychotic  depression, GERD, PTSD, cognitive impairment, and PUD. Patient received his  3rd COVID-19 Pfizer vaccine on 10/6/2021. (Previous Pfizer COVID-19 doses  given on 12/23/2020 and 1/13/2021. ) He was admitted for observation for  tachycardia, fevers, and hypoxia on 10/7/2021. Received acetaminophen po and  2L IV fluids and observed overnight with resolution of leukocytosis, normalization  of lactate level, and resolution of symptoms. He was discharged back to his  skilled nursing facility in stable condition the next day, 10/8/2021. The  presentation was thought to be "most likely due to a brief systemic inflammatory  response to the third COVID vaccine." Of note, patient had a similar presentation  after his 2nd COVID-19 Pfizer vaccine in January 2021.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Leukocytosis, Pyrexia, Tachycardia, Urine analysis normal, White blood cell count increased
Clinical narrative: Narrative: 78 yo MALE with history of psychotic depression, GERD, PTSD,  cognitive and PUD. 78 yo MALE with history of psychotic  depression, GERD, PTSD, cognitive impairment, and PUD. Patient received his  3rd COVID-19 Pfizer vaccine on 10/6/2021. (Previous Pfizer COVID-19 doses  given on 12/23/2020 and 1/13/2021. ) He was admitted for observation for  tachycardia, fevers, and hypoxia on 10/7/2021. Received acetaminophen po and  2L IV fluids and observed overnight with resolution of leukocytosis, normalization  of lactate level, and resolution of symptoms. He was discharged back to his  skilled nursing facility in stable condition the next day, 10/8/2021. The  presentation was thought to be "most likely due to a brief systemic inflammatory  response to the third COVID vaccine." Of note, patient had a similar presentation  after his 2nd COVID-19 Pfizer vaccine in January 2021.
Age: 98.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Death
Clinical narrative: Narrative: Hospice part of the facility.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Flushing, Paraesthesia, Throat irritation
Clinical narrative: Narrative: Pt started with symptoms of tingling in the left arm, scratchy throat and flushing within 5 minutes of administering the vaccine. Pt was given 25mg Benadryl stat, sx resolved.
Age: 76.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Aphasia, COVID-19, Death
Clinical narrative: Narrative: patient appeared to have been recovering from recent covid illness, she did not have fever and was at her baseline on 08/27. Covid dx 8/20/21. She did not receive the regeneron treatment as Advent never contacted patient to set up. Unclear if this was covid related or other illness. Advised to seek urgent/ER eval if this is inline with her goals of care. Reviewed LST and patient has made it clear to POA/caregivers and to myself as pcp that she does not want life sustaining treatment, intubation, cpr, defibrillation, artificial hydration or nutrition. POA feels that taking her to hospital now would go against her wishes and if she could speak she would want to stay home. referral to hospice. passed away in her sleep on 09/05/2021
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute myocardial infarction, COVID-19, COVID-19 pneumonia, Chest pain, Cough
Clinical narrative: Narrative: Patient presented to ER on 12/1/21 with SOB over the past 2 days and concerns for low O2 sats. Used home nasal cannula on occasion. PMH includes COPD GOLD C, T2DM with neuropathy, alcohol/HCV cirrhosis and HTN. Reported occasional left-sided chest pain, typically when coughing (dry cough). Noted to be hypoxic in ER and immediately placed on 2L of nosal cannula, which improved O2 sats. Elevated troponins. COVID-19 and RSV positive. Dx with COVID-19 pneumonia, type 2 myocardial infarction (demand ischemia) due to COVID infection, and pulmonary infiltrate/pleural effusion which may be due to COVID 19 or cirrhosis. Treated with dexamethasone (12/1-12/4). Patient left AMA on 12/4/21 Discharged on dexamethasone taper for 6 days and supportive care medications.
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Hypoxia, Lung infiltration, Myocardial ischaemia, Pleural effusion
Clinical narrative: Narrative: Patient presented to ER on 12/1/21 with SOB over the past 2 days and concerns for low O2 sats. Used home nasal cannula on occasion. PMH includes COPD GOLD C, T2DM with neuropathy, alcohol/HCV cirrhosis and HTN. Reported occasional left-sided chest pain, typically when coughing (dry cough). Noted to be hypoxic in ER and immediately placed on 2L of nosal cannula, which improved O2 sats. Elevated troponins. COVID-19 and RSV positive. Dx with COVID-19 pneumonia, type 2 myocardial infarction (demand ischemia) due to COVID infection, and pulmonary infiltrate/pleural effusion which may be due to COVID 19 or cirrhosis. Treated with dexamethasone (12/1-12/4). Patient left AMA on 12/4/21 Discharged on dexamethasone taper for 6 days and supportive care medications.
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Respiratory syncytial virus test positive, SARS-CoV-2 test positive, Troponin increased
Clinical narrative: Narrative: Patient presented to ER on 12/1/21 with SOB over the past 2 days and concerns for low O2 sats. Used home nasal cannula on occasion. PMH includes COPD GOLD C, T2DM with neuropathy, alcohol/HCV cirrhosis and HTN. Reported occasional left-sided chest pain, typically when coughing (dry cough). Noted to be hypoxic in ER and immediately placed on 2L of nosal cannula, which improved O2 sats. Elevated troponins. COVID-19 and RSV positive. Dx with COVID-19 pneumonia, type 2 myocardial infarction (demand ischemia) due to COVID infection, and pulmonary infiltrate/pleural effusion which may be due to COVID 19 or cirrhosis. Treated with dexamethasone (12/1-12/4). Patient left AMA on 12/4/21 Discharged on dexamethasone taper for 6 days and supportive care medications.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative: Patient expired on 1/1/22 under care of hospice service
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Headache, Laboratory test, Oropharyngeal pain, Pain
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/19, Pfizer, dose #1 04/09, Pfizer, dose #2 12/25 COVID swab, result: detected 12/23 pt cc: rhinorrhea, sore throat exposure: unknown 12/25 pt admitted to ED cc: "sore throat, headache, body aches, and requesting testing" dx: Covid positive status, acute pharyngitis, LOS: 1 day 12/26 SARS-COV-2 Variant Sequencing: pending 12/29 clinically resolved
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Pharyngitis, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/19, Pfizer, dose #1 04/09, Pfizer, dose #2 12/25 COVID swab, result: detected 12/23 pt cc: rhinorrhea, sore throat exposure: unknown 12/25 pt admitted to ED cc: "sore throat, headache, body aches, and requesting testing" dx: Covid positive status, acute pharyngitis, LOS: 1 day 12/26 SARS-COV-2 Variant Sequencing: pending 12/29 clinically resolved
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, COVID-19, COVID-19 pneumonia, Cough, Dyspnoea
Clinical narrative: Narrative: Patient presented to ER on 12/1/21 with cough and SOB. Reported cough, myalgias, fatigue, and generally not feeling well for several days. Home O2 sats have been lower than his normal. O2 in ER dropped to <90% with SOB. Dx with COVID-19 pneumonia. Past medical history of COPD, diabetes, continued tobacco use. Treated with dexamethasone (12/1-12/10), remdesivir (12/1-12/5), and supportive care. Pre-renal AKI upon admission, but improved. Discharged on 12/5/21 with dexamethasone. Received Pfizer COVID-19 VACCINE ON 12/30/21.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Malaise, Myalgia, Oxygen saturation decreased, SARS-CoV-2 test positive
Clinical narrative: Narrative: Patient presented to ER on 12/1/21 with cough and SOB. Reported cough, myalgias, fatigue, and generally not feeling well for several days. Home O2 sats have been lower than his normal. O2 in ER dropped to <90% with SOB. Dx with COVID-19 pneumonia. Past medical history of COPD, diabetes, continued tobacco use. Treated with dexamethasone (12/1-12/10), remdesivir (12/1-12/5), and supportive care. Pre-renal AKI upon admission, but improved. Discharged on 12/5/21 with dexamethasone. Received Pfizer COVID-19 VACCINE ON 12/30/21.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative: Patient expired in hospice house
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chills, Cough, Diarrhoea, Fatigue
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/05 Janssen, dose #1 12/28 COVID swab, result: detected 12/21 pt. cc: cough, chills, diarrhea, fatigue, fever, headache, myalgias, rhinorrhea, sore throat exposure: unknown
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Myalgia, Oropharyngeal pain, Pyrexia, Rhinorrhoea
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/05 Janssen, dose #1 12/28 COVID swab, result: detected 12/21 pt. cc: cough, chills, diarrhea, fatigue, fever, headache, myalgias, rhinorrhea, sore throat exposure: unknown
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/05 Janssen, dose #1 12/28 COVID swab, result: detected 12/21 pt. cc: cough, chills, diarrhea, fatigue, fever, headache, myalgias, rhinorrhea, sore throat exposure: unknown
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Exposure to SARS-CoV-2, Inappropriate schedule of product administration, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 05/05, Pfizer, dose #1 09/20, Pfizer, dose #2 12/24 COVID swab, result: detected 08/03 pt cc: exposure: unknown 12/24 pt admit ED cc: exposed to COVID from student dx: VIRAL SYNDROME LOS: 1 day 12/24 SARS-COV-2 Variant Sequencing: pending
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chills, Cough, Fatigue, Laboratory test
Clinical narrative: Narrative: COVID infection following COVID vaccine series 12/17/20 , Pfizer, dose #1 NON-CLINIC 01/06/2021, Pfizer, dose #2 NON-CLINIC 11/30/2021, Pfizer, dose #3 12/23 COVID swab, result: detected 12/22 pt cc: cough, chills, fatigue, fever, myalgias, rhinorrhea, sore throat exposure: unknown 12/23 SARS-COV-2 Variant Sequencing: pending
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Oropharyngeal pain, Pyrexia, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 12/17/20 , Pfizer, dose #1 NON-CLINIC 01/06/2021, Pfizer, dose #2 NON-CLINIC 11/30/2021, Pfizer, dose #3 12/23 COVID swab, result: detected 12/22 pt cc: cough, chills, fatigue, fever, myalgias, rhinorrhea, sore throat exposure: unknown 12/23 SARS-COV-2 Variant Sequencing: pending
Age: 100.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Death
Clinical narrative: Narrative: death
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Fatigue, Headache, Myalgia
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/10, Pfizer, dose #1 11/23, Pfizer, dose #2 12/07 COVID swab, result: not detected 12/23/21 COVID swab, result: detected 12/23 SARS-COV-2 Variant Sequencing: pending 1/4/22 COVID swab, result: detected 12/23 pt cc: cough, fatigue, fever, headache, myalgias, rhinorrhea, sore throat exposure: unknown 12/26/21 clinically resolved
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pyrexia, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/10, Pfizer, dose #1 11/23, Pfizer, dose #2 12/07 COVID swab, result: not detected 12/23/21 COVID swab, result: detected 12/23 SARS-COV-2 Variant Sequencing: pending 1/4/22 COVID swab, result: detected 12/23 pt cc: cough, fatigue, fever, headache, myalgias, rhinorrhea, sore throat exposure: unknown 12/26/21 clinically resolved
Age: 59.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Cough, Fatigue, Inappropriate schedule of product administration, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 01/13, Pfizer, dose #1 02/03, Pfizer, dose #2 09/09, Pfizer, dose #3 12/23 COVID swab, result: detected 12/20 pt cc: cough, fatigue, exposure: unknown 12/23 SARS-COV-2 Variant Sequencing: pending
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Abnormal behaviour
Clinical narrative: Narrative: Patient's caregivers reported adverse reaction to first dose of Moderna vaccine with behavior change. Patient has history of moderate to severe vascular dementia with bipolar disorder and cognitive impairment.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chills, Diarrhoea, Fatigue, Headache
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/16, Pfizer, dose #1 03/09, Pfizer, dose #2 12/23 COVID swab, result: detected 12/23 pt cc: chills, diarrhea, fatigue, fever, headache, myalgias, rhinorrhea, sore throat exposure: unknown 12/23 SARS-COV-2 Variant Sequencing: pending
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Myalgia, Oropharyngeal pain, Pyrexia, Rhinorrhoea
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/16, Pfizer, dose #1 03/09, Pfizer, dose #2 12/23 COVID swab, result: detected 12/23 pt cc: chills, diarrhea, fatigue, fever, headache, myalgias, rhinorrhea, sore throat exposure: unknown 12/23 SARS-COV-2 Variant Sequencing: pending
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/16, Pfizer, dose #1 03/09, Pfizer, dose #2 12/23 COVID swab, result: detected 12/23 pt cc: chills, diarrhea, fatigue, fever, headache, myalgias, rhinorrhea, sore throat exposure: unknown 12/23 SARS-COV-2 Variant Sequencing: pending
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, COVID-19 pneumonia, Chest X-ray normal
Clinical narrative: Narrative: COVID infection following COVID vaccine series 04 16, Pfizer, dose #1 05/07, Pfizer, dose #2 12/24 COVID swab, result: detected 12/23 pt cc: cough, fatigue, fever, loss of taste or smell, sore throat exposure: unknown 12/26 pt admit ED cc: wheezing and chest pain dx: covid pneumonitis LOS: I day 12/26 CXR impression: No acute cardiopulmonary disease. 12/29 clinically resolved
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Cough, Fatigue, Oropharyngeal pain, Pyrexia
Clinical narrative: Narrative: COVID infection following COVID vaccine series 04 16, Pfizer, dose #1 05/07, Pfizer, dose #2 12/24 COVID swab, result: detected 12/23 pt cc: cough, fatigue, fever, loss of taste or smell, sore throat exposure: unknown 12/26 pt admit ED cc: wheezing and chest pain dx: covid pneumonitis LOS: I day 12/26 CXR impression: No acute cardiopulmonary disease. 12/29 clinically resolved
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Wheezing
Clinical narrative: Narrative: COVID infection following COVID vaccine series 04 16, Pfizer, dose #1 05/07, Pfizer, dose #2 12/24 COVID swab, result: detected 12/23 pt cc: cough, fatigue, fever, loss of taste or smell, sore throat exposure: unknown 12/26 pt admit ED cc: wheezing and chest pain dx: covid pneumonitis LOS: I day 12/26 CXR impression: No acute cardiopulmonary disease. 12/29 clinically resolved
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Inappropriate schedule of product administration, Oropharyngeal pain, Pain
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/18, Pfizer, dose #1 02/08, Pfizer, dose #2 09/01, Pfizer, dose #3 12/24 COVID swab, result: detected 12/22 pt cc: cough, fever, sore throat, rhinorrhea, exposure: unknown  12/24 pt admit to ED cc: cough and body aches dx: Covid-19 infection LOS: 1 dose  12/24 SARS-COV-2 Variant Sequencing: pending 12/29 clinically resolved
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/18, Pfizer, dose #1 02/08, Pfizer, dose #2 09/01, Pfizer, dose #3 12/24 COVID swab, result: detected 12/22 pt cc: cough, fever, sore throat, rhinorrhea, exposure: unknown  12/24 pt admit to ED cc: cough and body aches dx: Covid-19 infection LOS: 1 dose  12/24 SARS-COV-2 Variant Sequencing: pending 12/29 clinically resolved
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray normal, Cough, Fatigue, Headache
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/16, Pfizer, dose #1 02/06, Pfizer, dose #2 12/25 COVID swab, result: detected 12/25 pt cc: cough, fatigue, fever, headache, myalgias, nausea, sore throat, exposure: unknown 12/25 CXR impression: No acute abnormality.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Oropharyngeal pain, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/16, Pfizer, dose #1 02/06, Pfizer, dose #2 12/25 COVID swab, result: detected 12/25 pt cc: cough, fatigue, fever, headache, myalgias, nausea, sore throat, exposure: unknown 12/25 CXR impression: No acute abnormality.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Atelectasis, COVID-19, Chest X-ray abnormal, Cough, Lung consolidation
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/23, Pfizer, dose #1 04/13, Pfizer, dose #2 12/25 COVID swab, result: detected 12/22 pt cc: cough, exposure: unknown 12/25 pt admit ED cc: cough dx: covid 19 infection LOS: I day 12/25 CXR impression: Lungs: Mild left retrocardiac opacity which may represent atelectasis versus early consolidation.. Cardiomediastinal silhouette: No enlargement of the cardiomediastinal silhouette. Bones and soft tissues: No acute finding. 12/29 clinically resolved
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Lung opacity, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/23, Pfizer, dose #1 04/13, Pfizer, dose #2 12/25 COVID swab, result: detected 12/22 pt cc: cough, exposure: unknown 12/25 pt admit ED cc: cough dx: covid 19 infection LOS: I day 12/25 CXR impression: Lungs: Mild left retrocardiac opacity which may represent atelectasis versus early consolidation.. Cardiomediastinal silhouette: No enlargement of the cardiomediastinal silhouette. Bones and soft tissues: No acute finding. 12/29 clinically resolved
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Abscess limb, Bacteraemia, COVID-19, Hypoxia, Nausea
Clinical narrative: Narrative: PRESENTED TO ED WITH FEVER, N/V SX X 3 DAYS. TESTED POSITIVE FOR COVID11-12-21. WAS ADMITTED FOR COVID AND HAD MILD HYPOXIA, TREATED WITH REMDESIVIR AND DEX, BUT RAPIDLY WEANED OFF 02. REMAINDER OF STAY MOSTLY DEDICATED TO BACTEREMIA AND L FOOT ABSCESS.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive, Vomiting
Clinical narrative: Narrative: PRESENTED TO ED WITH FEVER, N/V SX X 3 DAYS. TESTED POSITIVE FOR COVID11-12-21. WAS ADMITTED FOR COVID AND HAD MILD HYPOXIA, TREATED WITH REMDESIVIR AND DEX, BUT RAPIDLY WEANED OFF 02. REMAINDER OF STAY MOSTLY DEDICATED TO BACTEREMIA AND L FOOT ABSCESS.
Age: 69.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Dyspnoea
Clinical narrative: Narrative:  68 year old male admitted on 1/11/22 with SOB and treatment of COVID-19 infection. He had been vaccinated x 2 with Moderna (1st dose: 2/11/21, 2nd dose 3/10/21). He received 5 days of remdesivir and 6 days of IV dexamethasone for treatment and was discharged on 1/18/22.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray normal, Chest pain, Cough, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 05/22, Morderna  , dose #1 (private sector- Publix) 06/19, Moderna  , dose #2 (private sector- Publix) 12/25 COVID swab, result: detected 12/25 pt cc: exposure: unknown 12/25 pt admit to ED cc: cough with chest pain dx: covid 19 infection LOS:  1 day 12/25 SARS-COV-2 Variant Sequencing: pending 12/25 CXR impression: No acute cardiopulmonary abnormality.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Inappropriate schedule of product administration, Oropharyngeal pain, Rhinorrhoea
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 04/28, MODERNA, dose #1 (non-facility) 05/28, MODERNA, dose #2 (non-facility) 12/27 COVID swab, result: detected 12/23 pt cc: cough, rhinorrhea, sore throat exposure: unknown clinically resolved
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 04/28, MODERNA, dose #1 (non-facility) 05/28, MODERNA, dose #2 (non-facility) 12/27 COVID swab, result: detected 12/23 pt cc: cough, rhinorrhea, sore throat exposure: unknown clinically resolved
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/17, Pfizer, dose #1 04/08, Pfizer, dose #2 11/24, Pfizer, dose #3 12/27 COVID swab, result: detected 12/27 pt cc: exposure: unknown
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/24, Pfizer, dose #1 03/17, Pfizer, dose #2 12/24 COVID swab, result: detected 12/24 pt cc: exposure: unknown
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chills, Cough, Diarrhoea, Nasopharyngitis
Clinical narrative: Narrative COVID infection following COVID vaccine series 04/13, Pfizer,  dose #1 05/04, Pfizer, dose #2 09/10 COVID-19 ANTIGEN (BINAX): not detected 12/24 COVID swab, result: detected 12/22 pt cc: cough, diarrhea, exposure: unknown 12/24 SARS-COV-2 Variant Sequencing: pending 12/24  pt admit ED cc: intermittent fevers and chills dx: COVID 19 nasopharyngitis LOS: 1  day
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test negative, SARS-CoV-2 test positive
Clinical narrative: Narrative COVID infection following COVID vaccine series 04/13, Pfizer,  dose #1 05/04, Pfizer, dose #2 09/10 COVID-19 ANTIGEN (BINAX): not detected 12/24 COVID swab, result: detected 12/22 pt cc: cough, diarrhea, exposure: unknown 12/24 SARS-COV-2 Variant Sequencing: pending 12/24  pt admit ED cc: intermittent fevers and chills dx: COVID 19 nasopharyngitis LOS: 1  day
Age: 76.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Cough, Dyspnoea, SARS-CoV-2 test positive
Clinical narrative: Narrative:  75 year old female who tested positive for COVID on 1/8/22 and was admitted for non-productive cough and worsening dyspnea. She had received Pfizer vaccine on 1/21/2021 and 2/11/2021. Notes reported that patient had also received a booster dose, however there are no records of patient receiving that booster dose at any facility. Do not know the date of the booster or if booster dose was Pfizer or moderna. Patient was treated with 5 days of remdesivir and 5 days of dexamethasone prior to discharge on 1/14/22.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray normal, Chills, Cough, Diarrhoea
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/27, Pfizer, dose #1 04/16, Pfizer, dose #2 12/24 COVID swab, result: detected 12/24 pt cc: chills, cough, diarrhea, fatigue, headache, nausea, rhinorrhea, sore throat exposure: unknown 12/24 CXR impression: No acute cardiopulmonary disease. 12/24 SARS-COV-2 Variant Sequencing: pending 12/24 pt admit ED cc: covid sx dx: Covid-19 LOS: I day 12/29 clinically resolved
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Nausea, Oropharyngeal pain, Rhinorrhoea
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/27, Pfizer, dose #1 04/16, Pfizer, dose #2 12/24 COVID swab, result: detected 12/24 pt cc: chills, cough, diarrhea, fatigue, headache, nausea, rhinorrhea, sore throat exposure: unknown 12/24 CXR impression: No acute cardiopulmonary disease. 12/24 SARS-COV-2 Variant Sequencing: pending 12/24 pt admit ED cc: covid sx dx: Covid-19 LOS: I day 12/29 clinically resolved
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/27, Pfizer, dose #1 04/16, Pfizer, dose #2 12/24 COVID swab, result: detected 12/24 pt cc: chills, cough, diarrhea, fatigue, headache, nausea, rhinorrhea, sore throat exposure: unknown 12/24 CXR impression: No acute cardiopulmonary disease. 12/24 SARS-COV-2 Variant Sequencing: pending 12/24 pt admit ED cc: covid sx dx: Covid-19 LOS: I day 12/29 clinically resolved
Age: 92.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  91yo with CURRENT PROBLEM LIST:  Vitreous Detachment/Degeneration (PVD) Actinic Keratosis Personal History of BCC/SCC Pain in joint involving forearm (ICD-9-CM 719.43) Attention- Deficit/Hyperactivity DisorderSprain (ICD-9-CM 599.7) Nephrolithiasis (ICD-9-CM 592.0) CA PROSTATE SKIN LESION CAD HYPERLIPIDEMIA HYPERTENSION died at outside community hospital on 12/27/2021. Pt had received 3 covid vaccines on 1/15/21, 2/12/21, & 9/2/21. Circumstances of pt's death not known. Likely pt's death is not related to covid vaccines given pt's advanced age, comorbidies, and long length of time between death & date of vaccine administrations.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chills, Cough, Dyspnoea, Fatigue
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/26, Pfizer, dose #1 02/19 Pfizer, dose #2 12/23 Pfizer, dose #3 12/27 COVID swab, result: detected 12/27 pt cc: chills cough, fatigue, fever, headache, rhinorrhea, dyspnea, sore throat exposure: unknown
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Inappropriate schedule of product administration, Oropharyngeal pain, Pyrexia, Rhinorrhoea
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/26, Pfizer, dose #1 02/19 Pfizer, dose #2 12/23 Pfizer, dose #3 12/27 COVID swab, result: detected 12/27 pt cc: chills cough, fatigue, fever, headache, rhinorrhea, dyspnea, sore throat exposure: unknown
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/26, Pfizer, dose #1 02/19 Pfizer, dose #2 12/23 Pfizer, dose #3 12/27 COVID swab, result: detected 12/27 pt cc: chills cough, fatigue, fever, headache, rhinorrhea, dyspnea, sore throat exposure: unknown
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Inappropriate schedule of product administration, Oropharyngeal pain, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/10, Pfizer, dose #1 03/03, Pfizer, dose #2 10/18, Pfizer, dose #3 10/15 COVID swab, result: not detected 12/27 COVID swab, result: detected 1/6 COVID swab, result: detected 12/26 pt cc: rhinorrhea, sore throat exposure: unknown
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Cough, Diarrhoea
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 05/12, Pfizer, dose #1 06/02, Pfizer, dose #2 12/24 COVID swab, result: detected 12/20 pt cc: cough, loss of taste or smell, rhinorrhea, diarrhea, nausea exposure: family 12/29 clinically resolved
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Exposure to SARS-CoV-2, Nausea, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 05/12, Pfizer, dose #1 06/02, Pfizer, dose #2 12/24 COVID swab, result: detected 12/20 pt cc: cough, loss of taste or smell, rhinorrhea, diarrhea, nausea exposure: family 12/29 clinically resolved
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray normal, Cough, Inappropriate schedule of product administration, Rhinorrhoea
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/18, Pfizer, dose #1 04/08, Pfizer, dose #2 12/26 COVID swab, result: detected 12/23 pt cc: cough, rhinorrhea exposure: unknown 12/26 CXR impression: No acute cardiopulmonary abnormality. 12/26 SARS-COV-2 Variant Sequencing: pending 12/26 pt admit ED cc: Covid test dx: Covid-19 LOS: 1 day
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/18, Pfizer, dose #1 04/08, Pfizer, dose #2 12/26 COVID swab, result: detected 12/23 pt cc: cough, rhinorrhea exposure: unknown 12/26 CXR impression: No acute cardiopulmonary abnormality. 12/26 SARS-COV-2 Variant Sequencing: pending 12/26 pt admit ED cc: Covid test dx: Covid-19 LOS: 1 day
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Chest X-ray normal, Chills
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 04/29, NOVAVAX, dose #1 (PRIVATE SECTOR HEALTH) 05/21, NOVAVAX dose #2 (PRIVATE SECTOR HEALTH) 12/26 pt admit ED cc: "Loss of taste and smell, cough, wheezing & sore throat for 3-4 days" dx: COVID + LOS: 1 day 12/26 COVID swab, result: detected 12/22 pt cc: chills, cough, fatigue, fever, headache, loss of taste or smell, myalgias, sore throat exposure: unknown 12/26 SARS-COV-2 Variant Sequencing: pending 12/26 CXR impression: No lobar pneumonia. Correlate with COVID testing as plain radiographs are sensitive for mild disease. 12/29 clinically resolved
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Fatigue, Headache, Myalgia, Oropharyngeal pain
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 04/29, NOVAVAX, dose #1 (PRIVATE SECTOR HEALTH) 05/21, NOVAVAX dose #2 (PRIVATE SECTOR HEALTH) 12/26 pt admit ED cc: "Loss of taste and smell, cough, wheezing & sore throat for 3-4 days" dx: COVID + LOS: 1 day 12/26 COVID swab, result: detected 12/22 pt cc: chills, cough, fatigue, fever, headache, loss of taste or smell, myalgias, sore throat exposure: unknown 12/26 SARS-COV-2 Variant Sequencing: pending 12/26 CXR impression: No lobar pneumonia. Correlate with COVID testing as plain radiographs are sensitive for mild disease. 12/29 clinically resolved
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive, Wheezing
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 04/29, NOVAVAX, dose #1 (PRIVATE SECTOR HEALTH) 05/21, NOVAVAX dose #2 (PRIVATE SECTOR HEALTH) 12/26 pt admit ED cc: "Loss of taste and smell, cough, wheezing & sore throat for 3-4 days" dx: COVID + LOS: 1 day 12/26 COVID swab, result: detected 12/22 pt cc: chills, cough, fatigue, fever, headache, loss of taste or smell, myalgias, sore throat exposure: unknown 12/26 SARS-COV-2 Variant Sequencing: pending 12/26 CXR impression: No lobar pneumonia. Correlate with COVID testing as plain radiographs are sensitive for mild disease. 12/29 clinically resolved
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Endotracheal intubation, Swollen tongue
Clinical narrative: Narrative:  Patient was intubated as a result of tongue swelling following second dose of COVID-19 vaccine. Of note, patient reported to staff he had consumes claims and chicken for dinner prior to reaction as well.
Age: 93.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative: Patient was an 85 yo on hospice with h/o: Anxiety/Depression/Dementia with behavioral disturbances/Sleep-wake schedule disorder/Coronary artery disease/CHEST PAIN/Benign essential hypertension/Hyperlipidemia/Postural hypotension/ Atrial fibrillation/Stented artery/history of fall/seizures. Was receiving all medications from hospice at time of death. Goals of care were to live day by day.
Age: 60.0
Sex: M
Vaccine: FLUX
Symptoms: Urticaria
Clinical narrative: Narrative:  per clinic and notes, patient experienced urticaria with influenza vaccine.  Vaccine was administered at a clinic on 11/11/2021 per notes (per clinic), this could not obtain adequate information on the reaction.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Adverse reaction, Dyspnoea, Migraine, Photophobia, Urticaria
Clinical narrative: Narrative:  Hospitalized in March for a migraine after the first COVID Pfizer Shot. Hospitalized in March again SOB and wheezing. She attributes this to the Covid vaccines. Booster shot caused generalized hives which she sough medical treatment for and was treated with steroids at an urgent care. Per patient: "Yesterday I went to the Medical Center for the Phizer first dose COVID vaccine. I had a severe adverse reaction. I had a migraine with sensitive to light, and vomiting due to vertigo. I called 911 and went to Hospital. They treated me with Fioricet, Ibuprofen, and Zofran."
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Vertigo, Vomiting, Wheezing
Clinical narrative: Narrative:  Hospitalized in March for a migraine after the first COVID Pfizer Shot. Hospitalized in March again SOB and wheezing. She attributes this to the Covid vaccines. Booster shot caused generalized hives which she sough medical treatment for and was treated with steroids at an urgent care. Per patient: "Yesterday I went to the Medical Center for the Phizer first dose COVID vaccine. I had a severe adverse reaction. I had a migraine with sensitive to light, and vomiting due to vertigo. I called 911 and went to Hospital. They treated me with Fioricet, Ibuprofen, and Zofran."
Age: 43.0
Sex: M
Vaccine: FLUA4
Symptoms: Fatigue, Malaise, Pyrexia
Clinical narrative: Narrative:  A 42yo male with PMH of Foot Pain, Neck Pain, Pain Radiating to Right Shoulder, Cervicalgia, Alopecia, Hip Pain, GERD, and Low Back Pain. On November 016, 2021, the patient was reported with a historical ADR of influenza vaccine induced fever, fatigue and malaise, by RN. No other information regarding the vaccine has been provided,
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Fatigue, Nasal congestion, Oropharyngeal pain
Clinical narrative: COVID infection following COVID vaccine series 02/26, Pfizer doe #1 03/19, Pfizer dose #2 12/21, Pfizer dose #3 12/26 COVID swab, result: detected 12/23 12/23 ot cc: cough, fatigue exposure: unknown 12/26 pt admit ED cc: "mild sore throat", congested nose, more phlegm in his throat," dx: Covid with respiratory multiplex LOS; 1 day 12/29 clinically resolved
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Productive cough, Respiratory viral panel, SARS-CoV-2 test positive
Clinical narrative: COVID infection following COVID vaccine series 02/26, Pfizer doe #1 03/19, Pfizer dose #2 12/21, Pfizer dose #3 12/26 COVID swab, result: detected 12/23 12/23 ot cc: cough, fatigue exposure: unknown 12/26 pt admit ED cc: "mild sore throat", congested nose, more phlegm in his throat," dx: Covid with respiratory multiplex LOS; 1 day 12/29 clinically resolved
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Diarrhoea, Fatigue, Headache, Inappropriate schedule of product administration
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/25, Pfizer, dose #1 08/30, Pfizer, dose #2 12/7 COVID swab, result: not detected 12/26 COVID swab, result: detected 12/01 pt cc: Fatigue, body aches, headache., diarrhea. exposure: unknown 12/07 pt admit ED cc: Fatigue, body aches dx: Acute Viral Syndrome LOS: 1 day 12/26 SARS-COV-2 Variant Sequencing: pending
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, SARS-CoV-2 test positive, Viral infection
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/25, Pfizer, dose #1 08/30, Pfizer, dose #2 12/7 COVID swab, result: not detected 12/26 COVID swab, result: detected 12/01 pt cc: Fatigue, body aches, headache., diarrhea. exposure: unknown 12/07 pt admit ED cc: Fatigue, body aches dx: Acute Viral Syndrome LOS: 1 day 12/26 SARS-COV-2 Variant Sequencing: pending
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Inappropriate schedule of product administration, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 01/25, Pfizer, dose #1 02/16, Pfizer, dose #2 09/30, Pfizer, dose #3 1/11 COVID swab, result: detected 1/11 pt cc: exposure: unknown
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Fatigue, Headache, Myalgia, Rhinorrhoea
Clinical narrative: COVID infection following COVID vaccine series 03/31, Pfizer, dose #1 04/21, Pfizer, dose #2 12/26 COVID swab, result: detected 12/23 pt cc: fatigue, headache, myalgias, exposure: unknown 12/26 pt admit ED cc: " fatigue, myalgia, rhinorrhea and headache since last night" dx: COVID-19 LOS: 1 day 12 26 SARS-COV-2 Variant Sequencing: pending 12/30 clinically resolved
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: COVID infection following COVID vaccine series 03/31, Pfizer, dose #1 04/21, Pfizer, dose #2 12/26 COVID swab, result: detected 12/23 pt cc: fatigue, headache, myalgias, exposure: unknown 12/26 pt admit ED cc: " fatigue, myalgia, rhinorrhea and headache since last night" dx: COVID-19 LOS: 1 day 12 26 SARS-COV-2 Variant Sequencing: pending 12/30 clinically resolved
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Deep vein thrombosis
Clinical narrative: Narrative:  Patient reported receiving the J&J COVID19 vaccine on 9/17/21. Three weeks later 10/3/21, patient was admitted to Hospital ED where they confirmed DVT of right popliteal and right posterior tibial veins.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Myalgia, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 06/30, Moderna , dose #1  06/02, Moderna , dose #2 12/23 COVID swab, result: detected 12/20 pt cc: cough, fever, myalgias, exposure: unknown 12/23 SARS-COV-2 Variant Sequencing: pending
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Immunodeficiency, SARS-CoV-2 test positive
Clinical narrative: Narrative:  Patient received COVID Booster 11/16/21. Patient tested positive for COVID 12/14/21. Patient was given Bamlanivimab + Etesevimab 12/17/21. Patient was admitted for COVID + / immunocompromised state 12/22/21.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, COVID-19, Chills, Cough, Fatigue
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 06/01 Janssen, dose #1 12/27 SARS-COV-2 Variant Sequencing: pending 12/27 COVID swab, result: detected 12/24 pt cc: chills, cough, fatigue, fever, headache, myalgias, rhinorrhea, sore throat exposure: unknown 12/27 pt admit ED cc: LOW BACK PAIN / HEADACHE dx: CPVOD-19 infection LOS:  1 day
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Myalgia, Oropharyngeal pain, Pyrexia, Rhinorrhoea
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 06/01 Janssen, dose #1 12/27 SARS-COV-2 Variant Sequencing: pending 12/27 COVID swab, result: detected 12/24 pt cc: chills, cough, fatigue, fever, headache, myalgias, rhinorrhea, sore throat exposure: unknown 12/27 pt admit ED cc: LOW BACK PAIN / HEADACHE dx: CPVOD-19 infection LOS:  1 day
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 06/01 Janssen, dose #1 12/27 SARS-COV-2 Variant Sequencing: pending 12/27 COVID swab, result: detected 12/24 pt cc: chills, cough, fatigue, fever, headache, myalgias, rhinorrhea, sore throat exposure: unknown 12/27 pt admit ED cc: LOW BACK PAIN / HEADACHE dx: CPVOD-19 infection LOS:  1 day
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chills, Cough, Inappropriate schedule of product administration, Myalgia
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/19, Pfizer, dose #1 03/16, Pfizer, dose #2 1/2/2022 COVID swab, result: detected 12/25 pt cc: Myalgias, chills, cough, fever, rhinorrhea exposure: unknown  12/26 COVID swab, result: detected 12/26 SARS-COV-2 Variant Sequencing: pending 12/27 pt admit ED cc: URI sx, dx: Covid-19 LOS: 1 day
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Respiratory symptom, Rhinorrhoea, SARS-CoV-2 test positive, Upper respiratory tract infection
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/19, Pfizer, dose #1 03/16, Pfizer, dose #2 1/2/2022 COVID swab, result: detected 12/25 pt cc: Myalgias, chills, cough, fever, rhinorrhea exposure: unknown  12/26 COVID swab, result: detected 12/26 SARS-COV-2 Variant Sequencing: pending 12/27 pt admit ED cc: URI sx, dx: Covid-19 LOS: 1 day
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Inappropriate schedule of product administration, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/10, Pfizer, dose #1 03/31, Pfizer, dose #2 12/27 COVID swab, result: detected 12/27 pt cc: exposure: unknown
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chills, Dyspnoea, Fatigue, Headache
Clinical narrative: Narrative: COVID infection following COVID vaccine serious 04/01, MODERNA, dose #1 05/01, MODERNA, dose #2 12/27 COVID swab, result: detected 12/23 pt cc: chills, cough, fatigue, fever, headache, myalgias, rhinorrhea, dyspnea, sore throat exposure: unknown